The firm is an early-stage venture capital fund established by a group of experienced medical device industry professionals in Asia. The firm typically invests approximately $700K–$3M in companies raising Angel, Pre-Series A, Series A, and Series B financings. The firm invests through a local-currency fund and therefore places a strong emphasis on international companies willing to establish a joint venture or meaningful operating presence in Asia. The firm’s partners leverage extensive medical device industry experience and local networks to help portfolio companies establish and grow their businesses in the Asian market.
The firm primarily invests in medical devices and in vitro diagnostics, with particular expertise in cardiology, neuromodulation, diagnostic technologies, and medical imaging. The firm is also interested in R&D services and AI-enabled healthcare technologies, particularly technologies that use artificial intelligence to improve medical imaging, diagnostic accuracy, or clinical efficiency. While these areas represent the firm’s core expertise, the firm remains open to other differentiated medical technologies with strong development and commercialization potential.
From a company and management team perspective, the firm strongly prefers opportunities with a clear Asia strategy and companies willing to collaborate closely with its investment partners. The firm can support international companies through local industry relationships, access to industrial and commercialization networks, and assistance in identifying potential non-dilutive funding opportunities. The firm seeks management teams that are receptive to strategic involvement and can leverage the firm’s operating experience and local resources to establish and expand their presence in Asia.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 